RxSight, Inc. Amortization of Debt Issuance Costs and Discounts
RxSight, Inc. (RXST) reported Amortization of Debt Issuance Costs and Discounts of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-02-25
- RxSight, Inc. amortization of debt issuance costs and discounts for the quarter ending 2024-12-31 was $0.00.
- RxSight, Inc. amortization of debt issuance costs and discounts for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- RxSight, Inc. amortization of debt issuance costs and discounts for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- RxSight, Inc. amortization of debt issuance costs and discounts for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- RxSight, Inc. amortization of debt issuance costs and discounts for fiscal 2025 was $0.00.
- RxSight, Inc. amortization of debt issuance costs and discounts for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- RxSight, Inc. amortization of debt issuance costs and discounts for fiscal 2023 was $287.00K, a 48.01% decline from fiscal 2022.
- RxSight, Inc. amortization of debt issuance costs and discounts for fiscal 2022 was $552.00K, a 11.97% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $0.00 10-Q · filed 2024-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-02-25 | $4.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $4.00K derived: sum of 3 quarters · filed 2026-02-25 | $146.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.00K derived: sum of 2 quarters · filed 2026-02-25 | $146.00K derived: sum of 3 quarters · filed 2026-02-25 | $287.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $146.00K derived: sum of 2 quarters · filed 2024-11-07 | $287.00K 10-Q · filed 2024-11-07 | $431.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $283.00K 10-Q · filed 2024-08-05 | $427.00K derived: sum of 3 quarters · filed 2025-02-25 | $570.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $141.00K 10-Q · filed 2024-05-06 | $285.00K derived: sum of 2 quarters · filed 2025-02-25 | $428.00K derived: sum of 3 quarters · filed 2025-02-25 | $563.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $287.00K derived: sum of 2 quarters · filed 2025-02-25 | $422.00K derived: sum of 3 quarters · filed 2025-02-25 | $552.00K 10-K · filed 2025-02-25 |
| 2022-09-30 | $143.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $278.00K derived: sum of 2 quarters · filed 2023-11-09 | $408.00K 10-Q · filed 2023-11-09 | $540.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $135.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $265.00K 10-Q · filed 2023-08-07 | $397.00K derived: sum of 3 quarters · filed 2023-08-07 | $529.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $130.00K 10-Q · filed 2023-05-09 | $262.00K derived: sum of 2 quarters · filed 2023-05-09 | $394.00K derived: sum of 3 quarters · filed 2023-05-09 | $509.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $264.00K derived: sum of 2 quarters · filed 2023-03-06 | $379.00K derived: sum of 3 quarters · filed 2023-03-06 | $493.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $247.00K derived: sum of 2 quarters · filed 2022-11-07 | $361.00K 10-Q · filed 2022-11-07 | $446.00K derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $229.00K 10-Q · filed 2022-08-08 | $314.00K derived: sum of 3 quarters · filed 2022-08-08 | $314.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $114.00K 10-Q · filed 2022-05-05 | $199.00K derived: sum of 2 quarters · filed 2022-05-05 | $199.00K derived: sum of 3 quarters · filed 2022-05-05 | |
| 2020-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $85.00K derived: sum of 2 quarters · filed 2022-03-08 | $85.00K 10-K · filed 2022-03-08 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |